• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Dexcom

Insulet makes Omnipod 5 available with Dexcom G7 15 Day CGM

December 2, 2025 By Sean Whooley

Insulet Omnipod 5 Dexcom G7 15 Day

Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 Day CGM. Acton, Massachusetts-based Insulet, which has paired its pumps with previous versions of Dexcom continuous glucose monitors (CGMs), has offered Omnipod 5 with the initial version of G7 since early 2024. However, Dexcom received FDA clearance for people […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Insulet

Dexcom to launch G7 15 Day CGM next month

November 20, 2025 By Sean Whooley

Dexcom G7 15 Day CGM in use (1)

Dexcom (NSDQ:DXCM) announced today that it plans to launch its G7 15 Day continuous glucose monitor (CGM) in the U.S. next month. The San Diego–based company plans to make the CGM available for people over the age of 18 with diabetes on Dec. 1. Initially, the company plans to make the sensor available for users […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Dexcom wins FDA nod for smart CGM-integrated basal dosing for type 2 diabetes

November 19, 2025 By Sean Whooley

Dexcom Smart Basal insulin dosing type 2 diabetes with G7 CGM

Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer. The continuous glucose monitor (CGM)-based offering received clearance for adults with type 2 diabetes on glargine U-100 long-acting insulin therapy. San Diego-based Dexcom says it marks the first and only CGM-integrated basal dosing optimizer cleared for type 2 diabetes. […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Dexcom, FDA

What diabetes tech companies are doing on World Diabetes Day 2025

November 14, 2025 By Sean Whooley

World Diabetes day

Once again, World Diabetes Day, celebrated on Nov. 14 every year, has come around, highlighting new initiatives in the diabetes tech space. The date marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. It also lands during the American Diabetes Association’s National Diabetes Awareness Month. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, American Diabetes Association, Ascensia Diabetes Care, Breakthrough T1D, Dexcom, embecta, Insulet, Juvenile Diabetes Research Foundation (JDRF), Medtronic, Renu MedTech, Sequel Med Tech, ViCentra, World Diabetes Day 2025

Dexcom unveils new advocates to support World Diabetes Day campaign

November 14, 2025 By Sean Whooley

Dexcom World Diabetes Day map graphic

Dexcom (NSDQ:DXCM) today announced 16 new advocates representing people with diabetes as part of its World Diabetes Day campaign. Today, Nov. 14, is World Diabetes Day, which marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. It also lands during the American Diabetes Association’s National […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Carrot, Oura, Dexcom partner on biosensor insights for fertility

November 13, 2025 By Sean Whooley

A person wears the Oura ring while scrolling the app looking at glucose values.

Carrot announced that it partnered with Oura and Dexcom to deliver actionable, personalized insights supporting fertility goals. The companies came together to provide actionable, personalized insights through the metabolic-fertility program, Sprints. This collaboration combines Carrot’s clinical expertise with advanced insights from Oura, a leading smart wearable ring maker, and Dexcom, a leading continuous glucose monitor […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology, Women's Health Tagged With: carrot, Dexcom, Oura

The top CGM stories of 2025

November 10, 2025 By Sean Whooley

Abbott-Freestyle

Millions of people worldwide are looking for ways to manage their diabetes. That’s where the continuous glucose monitor (CGM) comes in. The CGM market is expected to experience substantial, double-digit percentage growth over the next five years, reaching nearly $29 billion by 2030. Market leaders Abbott and Dexcom continue to establish their hold on the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, Patient Monitoring, Technology Tagged With: abbott, biolinq, Dexcom, Glucotrack, Medtronic, Senseonics

12 things you need to know about the CGM market

November 4, 2025 By Chrystal Larsen

Abbott-Freestyle

The CGM market is an exciting, fast-growing, multibillion-dollar sector for the medical device industry, according to our latest Medtech Market Intelligence Report for MassDevice. The report on the CGM market — available for purchase on MassDevice — draws on numerous sources, including but not limited to: medical associations, government data, medical journals, leading medtech publications, clinical […]

Filed Under: Diabetes, Diagnostics, Featured Tagged With: abbott, CGM, Dexcom, Medtronic, minimed, Senseonics

Dexcom leadership addresses G7 issue claims, hopes for expanded CGM coverage

October 31, 2025 By Sean Whooley

Dexcom G7 iPhone (1)

Amid some scrutiny over its latest-generation G7 continuous glucose monitor (CGM), Dexcom (Nasdaq:DXCM) officials addressed claims on the company’s latest earnings call. A recent class action lawsuit brought G7 into the spotlight, demanding a jury trial for claims that Dexcom’s representations for G7 were false, misleading, and deceptive to consumers. The lawsuit says G7 places […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

CGM market report: Significant growth is ahead

October 30, 2025 By Sean Whooley

This is the cover of the MassDevice Medtech Markets Intelligence Report about the CGM market.

As millions of people worldwide seek ways to manage their diabetes, the continuous glucose monitor (CGM) market continues to grow rapidly. Medtech market analysts project significant growth for the market over the next five years. Chrystal Larsen, a veteran medtech market analyst, produced a detailed report for MassDevice outlining the future of the CGM market. The report covers […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology, Wall Street Beat Tagged With: abbott, Dexcom, Medtronic, Senseonics

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Interim pages omitted …
  • Page 24
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS